Backed by our brilliant minds, we have turned the traditional CRO model on its head, by fostering a collaborative and personalised approach. Our mission is simple: Solve problems. Deliver quality data. Propel your drug discovery breakthroughs. United by a passion to make sense of complexities and overcome challenges, we apply our specialised knowledge to big-picture thinking. We will explore every option to deliver over and above for your project. We are thought leaders with a deep understanding of immunology, bioassays, molecular biology and a track record of groundbreaking discoveries and novel cell-based tools. For more information, visit https://rouken.bio/

We’re an end-to-end talent supplier - from preclinical to post market, through to research, development and technical operations. We qualify, engage and deliver candidates to your life sciences consulting jobs. Visit us to learn more about how our life science recruiters and FSP services can support your organization. For more information, please visit https://www.orbisclinical.com/

Intrepid Labs integrates AI, robotics, and advanced formulation science to accelerate drug development. Our proprietary VALIANT™ platform optimizes formulations for global pharma and CDMO partners. In parallel, we are advancing next-generation proprietary drug delivery technologies for use in oral and long-acting injectable formulations of small molecules and peptides. For more information, please visit https://intrepidlabs.tech/

For more information, please visit https://www.samyang.com/en/index

For more information, please visit https://www.phchd.com/global

Ozette is a biotechnology company pioneering vertically integrated and computationally-driven solutions for deep immune profiling. By combining advanced AI-driven analysis with high quality & high-dimensional single-cell data generation in our Laboratory, Ozette is transforming immunological insights into actionable knowledge, empowering biopharmaceutical companies to develop precision therapies for complex diseases.

For more information, please visit https://www.ozette.com/

ICON Biotech is a world leading healthcare intelligence and clinical research organisation, dedicated to the needs of small and mid-sized biopharma companies. With 8,000 dedicated staff, we help biotech organisations meet their critical milestones and deliver data and evidence-based results to investors, large pharma partners and regulatory authorities. For more information, please visit https://www.iconplc.com/sectors/biotech

Johnson & Johnson’s Innovative Health, Engagement, and Advocacy (IHE&A) serves as a central function for our global development, leading the expansion of capabilities to enhance trial operations and better serve patients. The IHE&A sub-team focuses on enabling global patient access to our drug development pipeline, partnering with key advocacy communities to amplify patient voices across the R&D industry, and future-proofing patient engagement strategy with impactful capabilities and solutions.

Miracle accelerates clinical trials with real-time, automated insights across enrollment, patient profiles, safety, labs, data management, forecasting, and more. By aggregating and harmonizing siloed data, Miracle helps biopharma companies reduce delays, make faster decisions, and centralize communication. Customers have cut months off trial timelines by eliminating manual processes and inefficiencies. For more information, please visit https://www.miracleml.com/

For more information, please visit https://www.nelipak.com/

Alpha Clinical is a boutique consulting firm specializing in clinical development, end-to-end pharmacovigilance services, regulatory affairs, and R&D consulting. We provide comprehensive solutions, including clinical operations, site management, medical affairs, and strategic due diligence, ensuring compliance with global standards while prioritizing patient safety. Our expertise drives excellence across the pharmaceutical and biotech industries. For more information, please visit https://alphaclinicaldevelopments.com/

H.C. Wainwright & Co., LLC is an investment bank dedicated to providing corporate finance, strategic advisory, sales & trading, research, and related services to public and private growth companies across multiple focuses and regions. The HCW team has been the leader in the CMPO (confidentially marketed public offerings), RD (registered direct offering) and PIPE (private investment in public equity) transaction markets since 1998. For more information, visit https://hcwco.com/